South African herbal teas, rooibos and honeybush, are increasingly enjoyed as healthy alternatives to Camellia sinensis teas. They contribute to the diet with bioactive phytochemicals not commonly found in foods. Major compounds of rooibos are the unique dihydrochalcone, aspalathin, and its flavone isomers, orientin and isoorientin. Honeybush contributes the xanthones, mangiferin and isomangiferin and the flavanones, eriocitrin, narirutin and hesperidin. All these compounds are either C-glucosides or O-rhamnoglucosides, which are poorly absorbed. Phase II metabolism and degradation by intestinal bacteria are important factors in their absorption. Modulation of drug metabolising enzymes is indicated which not only could affect the therapeutic window of drugs, but also the bioavailability of other dietary flavonoids.
honeybush, produced from endemic Cyclopia spp., was "rediscovered" in the 1990s [6] . Currently the Cyclopia species of commercial interest are C. intermedia, C. subternata and C. genistoides. Both the South African and international markets for honeybush are still very small, but growing. Characteristic of the Cyclopia spp. is the ubiquitous presence of the xanthone C-glucoside mangiferin [7] , one of its major phenolic constituents. Both types of herbal tea provide the consumer with a caffeine-free alternative antioxidant beverage, which together with their long history of use without any documented adverse effects, contributes to their popularity [5] .
The most common rooibos and honeybush teas on the market are their traditional, "fermented" products, produced from the leaves and thin stems of the respective plants. "Fermentation" entails extensive oxidation of the phenolic compounds, required for the formation of their sought-after sweetish flavour and red-brown to brown colour. Green, "unfermented" rooibos and honeybush recently entered the market, not only providing the consumer with another taste option, but also higher phenolic content and potential antioxidant activity [5] .
The present review discusses the phenolic composition of these herbal teas with the emphasis on their major compounds and relevance in the diet, as well as their possible health benefits based on their bioactivity, bioavailability and potential herb-drug interactions.
Phenolic composition
The major phenolic compounds present in rooibos and honeybush are shown in Figure 1 . The phenolic profiles of fermented rooibos and fermented honeybush teas (C. intermedia and C. subternata) are depicted in Figure 2 . Propagation by seeds causes large variation in phenolic composition of the plant material even within plantations [8] . Rooibos contains two unique compounds, namely the C-C linked dihydrochalcone glucoside, aspalathin [9] , and the cyclic dihydrochalcone, aspalalinin [10] . Nothofagin, a rare C-C linked dihydrochalcone glucoside, is also present, but in lower quantities than aspalathin. The only other known sources of nothofagin are the heartwood of Nothofagus fusca [11] and the bark of a Chinese medicinal plant Schoepfia chinensis [12] . Rooibos also contains the flavone (orientin and isoorientin) [13] and flavanone (dihydro-orientin and dihydro-isoorientin) [14] analogues of aspalathin. The corresponding flavone analogues of nothofagin are vitexin and isovitexin [15] , while the flavanone analogue of isovitexin is hemiphlorin [10] . Other flavones present in rooibos include chrysoeriol, luteolin and luteolin-7-Oglucoside, while the flavonols quercetin, quercetin-3-O-robinobioside, hyperoside, isoquercitrin and rutin [10, [14] [15] [16] [17] are also present. Phenolic acids, lignans and the coumarin, esculetin, have also been identified [10, 15, 18] . (+)-Catechin, commonly occurring in Camellia sinensis teas, has been detected in rooibos. Although rooibos is prized as a low tannin herbal tea, ca 50% of the hot water soluble solids are tannin-like substances [5] .
The content of the major rooibos flavonoids in fermented and unfermented tea is shown in Table 1 . Aspalathin and nothofagin are present in the highest concentration in unfermented rooibos. Both compounds are very susceptible to oxidation during fermentation. Other compounds present in smaller amounts include orientin, isoorientin, vitexin, isovitexin, isoquercitrin and rutin. These compounds are relatively stable during oxidation. Aspalathin, on the other hand, has been shown to be converted to orientin and isoorientin via its flavanone analogues under oxidative conditions [9, 18, 19] . This reaction can occur under oxidative conditions prevailing during fermentation [20] . Presumably similar reactions can occur for nothofagin, although no proof is available to date. The major compounds present in Cyclopia species (honeybush) quantitatively analyzed to date include mangiferin, isomangiferin and hesperidin [21] . The concentration of these compounds, as well as most of the other compounds, is reduced with fermentation (Table 1) , although the identity of the oxidation and/or degradation products is not known to date. Indepth characterization of the phenolic composition of C. intermedia (fermented) [22, 23] and C. subternata (unfermented) [24] has been carried out. In addition to the above-mentioned compounds, C. intermedia contains a number of flavanones (eriocitrin, narirutin, hesperetin, eriodictyol, naringenin), flavones (luteolin, diosmetin), flavonols (kaempferol glucosides), isoflavones (formononetin, calycosin, wistin, afrormosin) and coumestans (medicagol, flemmichapparin, sophorocoumestan B). The phenolic composition of C. subternata differed both quantitatively and qualitatively from that of C. intermedia. Compounds isolated include flavanones (eriocitrin, narirutin), flavones (luteolin, 5-deoxyluteolin, scolymoside) and an isoflavone (orobol). The common flavan-3-ol, (-)-epigallocatechin gallate (EGCG) from green and black Camellia sinensis tea, has also been isolated from C. subternata.
Rooibos and honeybush can contribute to flavonoid intake associated with a healthy diet such as the Mediterranean diet. Rooibos contains the unique compound, aspalathin, and a number of compounds not found in common food sources. Rooibos flavones (nothofagin, orientin, isoorientin, vitexin, isovitexin) are found in buckwheat sprouts [25] , and medicinal plant extracts, e.g. from bamboo [26] and lime leaves [27] . Rooibos flavonols, however, are found in common foods such as apples and olives ( Table 2 ). On the other hand, honeybush phenolic compounds are also present in common foods. The flavanones are widely distributed in citrus fruits, while mangoes also contain mangiferin and isomangiferin. Honeybush tea will make a smaller contribution to flavanone intake compared to citrus fruits, but has a much higher xanthone content than mangoes (Tables 1 and 2 ).
Health promoting properties
Antioxidant activity of rooibos and honeybush phenolic compounds forms the underlying basis of their health promoting properties. A comprehensive review on the health promoting properties of rooibos and honeybush was published recently [5] . For the purpose of this review the focus in this section will mainly fall on the comparative antioxidant activity and anticancer properties of rooibos and honeybush herbal teas and Camellia sinensis teas, as well as some of the major herbal tea phenolic compounds of interest. In addition, beneficial effects of mangiferin, hesperidin and eriocitrin on antioxidant parameters in rat models received particular attention in the following discussion. As only a limited number of test systems were used in the comparative studies, Table 3 summarises a selection of in vitro and in vivo activities of some of the compounds to provide a more detailed perspective on their antioxidant properties.
Antioxidant properties:
In vitro antioxidant tests showed that rooibos aqueous extracts are more active than those of honeybush, irrespective of the Cyclopia species (C. intermedia, C. subternata, C. sessiliflora and C. genistoides), while none were as effective as aqueous extracts of green tea (Camellia sinensis).
Unfermented rooibos was comparable to black tea [21] . On the other hand, the hepatic ORAC levels of rats fed the different teas for ten weeks, were marginally (P < 0.1) to significantly (P < 0.05) reduced by the green and black teas, while the herbal teas had no effect [28] . Considering gluthatione (GSH) levels, none of the teas had a significant effect, but oxidized gluthatione (GSSG) levels were decreased by all. Both unfermented and fermented rooibos, as well as unfermented honeybush were effective in increasing the GSH/GSSG ratio significantly. Fermented honeybush was only marginally effective, while no effect was demonstrated for green and black teas [28] . For this in vivo study only one Cyclopia species, i.e. C. intermedia, was investigated. Given the differences in qualitative and quantitative phenolic composition between Cyclopia species, it would be worthwhile to expand in vivo investigations to include other species.
An aspalathin-enriched extract, when administered in pill form for two weeks to 20 healthy subjects on a flavonoid-restricted diet did not affect the antioxidant status of the plasma as measured with the ABTS •+ and Cu 2+ -induced lipid peroxidation assays [29] . According to the xanthine/xanthine oxidase assay the plasma antioxidant status of the subjects were actually lower after the trial. These findings suggest that rooibos flavonoids, especially aspalathin, in the quantities ingested, did not compensate for the lower flavonoid consumption of the flavonoid-restricted diet.
In vitro testing demonstrated that aspalathin is a good radical scavenger (O 2 •-, DPPH • and ABTS •+ ) of comparable or slightly lower activity than quercetin [30] [31] [32] and EGCG [32] . However, aspalathin offered substantially less protection against Fe 2+ -induced microsomal lipid peroxidation than both these compounds [32] . Oxidation of aspalathin to the flavones, orientin and isoorientin, an event that not only can take place during fermentation of the plant material, but also during storage in a product such as a ready-to-drink rooibos iced tea [33] , led to reduced radical scavenging ability [30] [31] [32] and inhibition of lipid peroxidation [32] . Nothofagin was slightly less effective than aspalathin as radical scavenger, but it offered very little protection against Fe 2+ -induced microsomal lipid peroxidation [32] . Similarly its flavones, vitexin and isovitexin, were not effective inhibitors of microsomal lipid peroxidation. Nothofagin was not tested in the coupled linoleic acid-β-carotene bleaching assay, but in this test system vitexin was only slightly less effective than aspalathin [30] .
The antioxidant properties of mangiferin are well-studied and its ability as reactive oxygen species (ROS) scavenger, protecting various cells and Table 3 : Antioxidant activities of phenolic compounds from rooibos and honeybush.
Compound
In vitro antioxidant activity (cell-free assays) Cell-based and in vivo antioxidant activity Orientin Scavenges HO • and chelates iron [118] Scavenges O 2 •and DPPH • [119] Reduces γ-irradiation-induced DNA damage in rats [120] Reduces γ-irradiation-induced DNA damage in human lymphocytes [121] Isoorientin Inhibits LDL oxidation [122] Inhibits LA oxidation and scavenges ABTS •+ [123] Scavenges O 2 •and DPPH • [119] Decreases CCl 4 -induced oxidative stress in rat liver [124] Protects against oxidative damage by ROS in HepG2 cells [125] Vitexin Inhibits LDL oxidation [122] Inhibits lipid peroxidation and scavenges ABTS •+ [123] Scavenges O 2 •and DPPH • [119] Scavenges intracellular ROS in human dermal fibroblasts [126] Isovitexin Inhibits LDL oxidation [122] Inhibits lipid peroxidation and scavenges ABTS [131] Protects against H 2 O 2 -induced DNA damage in human lymphocytes [132] Mangiferin Inhibits lipid peroxidation [135] Inhibits Fe 2+ -induced mitochondrial lipid peroxidation [41] Reduces TPA-induced production of ROS by peritoneal macrophages, reduces DNA fragmentation and inhibits lipid peroxidation in mouse serum, hepatic mitochondria and microsomes [37] Inhibits rat macrophage activity [136] Reduces streptozotocin-induced oxidative damage to cardiac and renal tissues in rats [38] Reduces oxidative stress in isoproterenol-induced myocardial infarction in rats [39] Hesperidin
Scavenges O 2 •-[127] Inhibits lipid peroxidation [43] Scavenges ABTS •+ [129] Scavenges DPPH • [137] Active in crocin bleaching assay [138] Protects against oxidative DNA damage in diabetic rats [44] Reduces oxidative damage in S. cerevisiae cells [137] Decreases CCl 4 -induced oxidative stress in rat liver and kidney [45] Increases plasma antioxidant activity in rats [ Reduces ex vivo oxidative susceptibility of LDL [142] Shows cytoprotection against -ONOO-induced oxidative damage [140] Increases blood serum SOD activity in laying hens [143] Decreases deoxyribose-induced oxidative damage to osteoblastic MC3T3-E1 cells [ [149] Active in crocin bleaching assay [138] Reduces lipid peroxidation and DNA strand damage in isolated rat nuclei [150] Reduces ex vivo oxidative susceptibility of LDL [142] Improves antioxidant capacity of rat erythrocytes [151] Reduces amyloid β peptide-induced oxidative stress in PC12 nerve cells [152] Luteolin Inhibits Cu 2+ -induced LDL oxidation [153] Scavenges O 2 •- [148] Scavenges ABTS •+ [129] Protects against oxidative DNA damage [154] Protects against H 2 O 2 -induced DNA damage in human lymphocytes [132] Protects against ascorbate/Fe 2+ -induced oxidative stress in chick retinal cells [146] Inhibits H 2 O 2 /Fe 2+ -induced lipid peroxidation in Caco-2 intestinal cells [155] macrophages against oxidative stress has been demonstrated [references in 34 and 35] . This ability, together with the increase in intracellular GSH levels, is believed to suppress activation of NF-κB by the inflammatory agent, tumour nuclear factor (TNF) [36] . Treatment of mice with mangiferin reduced 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced production of the ROS species, superoxide anion and H 2 O 2 , by peritoneal macrophages. TPA-induced DNA fragmentation in hepatic and brain tissues, and lipid peroxidation in serum, hepatic mitochondria and microsomes, and brain homogenate supernatants were reduced by mangiferin [37] . Streptozotocin (STZ)-induced oxidative damage to cardiac and renal tissues in rats was reduced by mangiferin [38] . Mangiferin was reported to increase the activities of heart tissue enzymatic antioxidants and serum non-enzymatic antioxidant levels, such as the GSH antioxidant balance in rats subjected to isoproterenol (ISPH)-induced myocardial infarction. ISPH generates free radicals and stimulates lipid peroxidation [39] .
The relative potency of mangiferin within the context of honeybush polyphenols [21, 40] suggests its importance as a potential major contributor to the in vitro and in vivo antioxidant activity of honeybush. It is substantially more active than hesperidin, the other major honeybush compound, in radical scavenging and inhibition of Fe 2+ -induced microsomal lipid peroxidation [21, 40] . Its iron-complexing ability is considered the primary mechanism for protecting rat liver mitochondria against Fe 2+ -citrate induced lipid peroxidation [41] . Mangiferin forms a 2:1 complex with Fe 3+ that is more effective than mangiferin itself in scavenging superoxide radicals [42] .
The poor performance of hesperidin as antioxidant in in vitro assays, especially when compared to mangiferin [21, 40] and eriocitrin [43] , however, does not mean that it will not contribute to the overall in vivo antioxidant properties of honeybush. Hesperidin increased the GSH levels in the liver and kidneys of diabetic rats [44] . When fed to rats, it decreased oxidative stress caused by CCl 4 in the liver and kidney [45] . A very high dose of hesperidin (200 mg/kg body weight) improved the levels of endogenous antioxidant enzymes (SOD and catalase) and GSH in the liver. Eriocitrin suppressed oxidative stress in STZ-induced diabetic rats [44] . When administered to rats prior to acute exercise, eriocitrin also suppressed lipid peroxidation and GSSG levels in their liver, while maintaining GSH levels [46] .
Modulation of carcinogen metabolism and implications for antimutagenic properties:
The first report on the antimutagenic properties of the South African herbal teas indicated that aqueous extracts were more effective against mutagens requiring metabolic activation than direct acting mutagens [47] . Possible antimutagenic mechanisms involved, are interference with carcinogen metabolism and direct interaction with the reactive mutagenic metabolites, presumably by the polyphenolic constituents of the teas. To further elucidate the role of selected rooibos and honeybush polyphenols, the antimutagenic properties were assessed against two commonly known carcinogens, i.e. 2-acetylaminofluorene (2-AAF) and aflatoxin B 1 (AFB 1 ) [48, 49] . Varying effects on the mutagenic behaviour of 2-AAF and AFB 1 were observed for the phenolic compounds.
A detailed study of the rooibos flavonoids showed that the major compounds, aspalathin, nothofagin and their flavone analogues orientin and isoorientin, and vitexin and isovitexin, respectively, were only moderately protective [49] . The minor flavones, luteolin and chrysoeriol, exhibited the highest protective properties, very similar to EGCG. Flavonoid-mutagen interactions obtained include antimutagenic, comutagenic, promutagenic and mutagenic effects. Typical, atypical and threshold dose response effects were noticed, depending on the concentration of the respective flavonoid tested. For example quercetin and its 3-O-glucoside, isoquercitrin, acted as direct-acting mutagens and in the case of metabolic activation, as promutagens. Both displayed also antimutagenic and comutagenic responses, respectively, at high and low concentrations.
Of the honeybush flavonoids, luteolin (retested for comparative purposes), eriodictyol, and hesperetin exhibited the highest protection against AFB 1induced mutagenesis while, except for luteolin, a far weaker response was noticed against 2-AAF. Hesperidin, eriocitrin and mangiferin exhibited a similar, but weaker, antimutagenic response. Narirutin offered the weakest protection against AFB 1 . The stimulation or comutagenic effects of eriodictyol, hesperidin and narirutin on 2-AAFinduced mutagenesis were of interest, which could explain the enhancing effect of the aqueous extracts of C. genistoides [48] . Variations in the protection against mutagenic effects of carcinogens were ascribed to differences in the metabolic activation pathways [49] .
The underlying mechanisms involved in the protective properties of the different tea flavonoids are currently under investigation. A specific antimutagenic response appears to be a critical balance between (i) the stabilisation of the cytochrome P450 (CYP450) in the liver homogenate due to the antioxidant capacity of the flavonoid and (ii) the extent by which the carcinogen-CYP450 interaction, resulting in the formation of the reactive mutagenic metabolite, is inhibited. The protection against CYP450 breakdown is associated with the antioxidant and/or pro-oxidant properties of the teas [50, 51] . In this regard green tea (Camellia sinensis) exhibited a far weaker stabilising effect than unfermented rooibos, presumably by creating a pro-oxidant environment that supports CYP450 breakdown and hence decreases the formation of active mutagenic metabolites. The stabilisation and/or destabilisation could also explain the comutagenic properties of certain of the flavonoids known not to exhibit any mutagenic properties.
Interaction with CYP450, utilising spectral binding assays, also provided interesting results in that weak antimutagens such as aspalathin, mangiferin and hesperidin are weak modulators of drug-CYP450 binding while the reverse was noticed with the strong antimutagens, luteolin, hesperetin, chrysoeriol and eriodictyol [52] . The outcome of the antimutagenic property of a flavonoid will be determined by these interactions, as well as specific structure activity relationships. The extent of B-ring hydroxylation and glycosylation of the A ring determine the lipophilicity and hence the distribution of a compound between water and lipid phases within the cell [49] . The presence of a C4-keto group and a saturated 2,3 double bond in the C-ring increased the antimutagenic properties of the herbal tea flavonoids.
The metabolism of the herbal tea flavonoids is also of importance when conducting an antimutagenicity assay. This is of particular interest as the herbal teas significantly increased the activity of the phase II cytosolic enzymes glutathione S-transferase alpha and the UDP-glucuronosyl transferase [28] . The mutagenic properties of carcinogens were also modulated ex vivo by subcellular liver microsomal and cytosolic fractions of rats fed the herbal tea. This suggested that the tea constituents, presumably the polyphenols, are absorbed affecting the activity of the drug metabolising enzymes [53] . These enzymes are likely to interfere with the antimutagenic properties of the flavonoids. A recent study showed that aspalathin [54] and mangiferin (unpublished results) are metabolised by the UDP-glucuronosyl transferases. Aspalathin was also metabolised by the sulphotransferases. The phase II metabolism of the two flavonoids could explain their weak antimutagenic properties as it could interfere with their hydrophilic/hydrophobic interaction with CYP450 during carcinogen metabolism.
Bioavailability
Recent reviews cover absorption, bioavailability and metabolites of flavonoids [55] [56] [57] [58] . These reviews deal mostly with the more common flavonoids, such as quercetin and its glycosides (e.g. rutin and isoquercitin) and flavanols. Several studies indicate that the glycosides need to be hydrolysed to aglycones prior to intestinal absorption [58] . C-glycosides such as those present in rooibos and honeybush, however, are very stable and resistant to acid and hydrolytic enzymes [59] [60] [61] . Similar to drugs, flavonoids should have favourable ADME (adsorption, distribution, metabolism and excretion) properties. Compounds should be bioavailable and reach target organs in adequate concentrations to confer significant health benefits to humans. In the first instance the compound has to cross the lining of the gut wall and determining factors are, amongst others, molecular weight (MW), lipophilicity, polar surface area (PSA) and number of rotatable bonds (RB). Lipinski's "Rule of 5" predicts poor absorption or membrane permeation for compounds with a molecular weight (MW) more than 500, calculated partition coefficient (ClogP) values more than five, hydrogen bond acceptors (HBA) more than 10 and hydrogen bond donors (HBD) more than 5 [62] .
Considering Lipinski's "Rule of 5" [62] , both rooibos dihydrochalcones, aspalathin and nothofagin, as well as their respective flavone analogues, have 2 violations relating to the number of HBA and HBD (Table 4 ). For all, the MW and ClogP values are, respectively, less than 500 Da and 5. In the case of honeybush the xanthones, mangiferin and isomangiferin, violate the parameters for HBA and HBD, whilst the flavanones, hesperidin, narirutin and eriocitrin, violate three parameters. In addition to violation of parameters for the number of HBD and HBA, these flavanones have MW > 500 (Table 4) . Poor absorption or membrane permeability is indicated if two parameters are outside the cutoffs of the "Rule of 5" [62] . Other considerations for absorption are PSA and number of RB. For aspalathin, nothofagin, hesperidin and eriocitrin PSA is greater than 140 Å 2 and the number of RB more than 10, further indications that they would normally be poorly absorbed, unless actively transported [63, 64] . The isomers, orientin and isorientin, have a PSA < 140 Å 2 , but their number of rotatable bonds is 11. The respective lipophilic aglycones of the rooibos and honeybush glycosides do not violate any of the parameters of the "Rule of 5" (Table 4) , and their PSA values and number of RB suggest a high probability of good intestinal permeability.
Theoretical parameters, however, do not provide the complete picture. Other factors such as physiological variables, including regional permeability differences, pH and luminal and mucosal enzymes determine absorption of compounds [65] . Bioavailability is limited by metabolism and transport from intestinal cells back into the lumen by efflux pumps such as the ATP binding cassette (ABC) transporters [66, 67] , as well as their metabolism by intestinal and liver cytochrome P450 monooxygenases [68] and by intestinal microflora [69] . Matrix effects, i.e. presence of other polyphenols, sugar, etc., could influence absorption [70, 71] .
Since a great number of rooibos flavonoids and the xanthones of honeybush are C-glycosides, transformation into their corresponding aglycones with more favorable absorption molecular characteristics by human intestinal bacteria will be an important factor in their bioavailability. The bioavailability of aspalathin as a major flavonoid of rooibos and one of its most potent antioxidants in vitro is of the utmost importance for its physiological relevance. Huang et al. [72] demonstrated the concentration dependant transport of aspalathin across the intestinal epithelium, using the Caco-2 cell line, a model for intestinal permeability exhibiting enterocyte-like characteristics [73] . The transport of aspalathin was lower for the pure compound than when present in an extract of green rooibos, suggesting that other plant components may assist in its transport across the membrane. No attention was given to possible metabolic conversion during absorption. First-pass metabolism received attention in an in vitro study [54] . Metabolism of aspalathin using S9, isolated from rat liver as source of UDPglucuronosyltransferase, and uridine-5´-diphosphoglucuronic acid as cofactor showed the formation of one minor and one major glucuronic acid conjugate. Incubation with the cytosolic fraction as source of sulphotransferase and 3´-phosphoadenosine-5´phosphosulphate as cofactor led to the formation of a sulphate conjugate.
Oral bioavailability of aspalathin was determined, using the pig as model for human nutrition [74, 75] . An aspalathin-enriched, unfermented rooibos extract, equaling 157-167 mg aspalathin/kg body weight/day, was fed to pigs for 11 days [76] . No aspalathin or metabolites were found in the plasma, which was attributed to their extensive binding to plasma proteins. However, aspalathin and five metabolites were identified in the urine. Three metabolites were conjugated forms of aspalathin, i.e. methylated aspalathin, glucuronidated aspalathin, and aspalathin conjugated with both a glucuronic acid and a methyl group. The other metabolites were a glucuronidated aglycone of aspalathin and eriodictyol glucoside (dihydro-isoorientin), the flavanone counterpart of aspalathin, containing two glucuronic acid groups and one methyl group. No sulphated conjugates could be detected. The results thus showed that phase II enzyme metabolism predominantly occurred, but that liberation of the aglycone and biotransformation of aspalathin to a flavanone glycoside are minor metabolic pathways. Excretion of aspalathin and metabolites was completed after 36 h. Methylated aspalathin was the metabolite with the longest halflife. Given that the aglycone of aspalathin and its flavanone glycoside, dihydro-isoorientin, were shown to be present as conjugates in the urine [76] , a metabolic pathway is suggested based on that of phloretin [69] , neohesperidin chalcone [77] and eriodictyol [78] (Figure 3 ). ADME properties of the flavone C-glycosides, orientin, isoorientin, vitexin and isovitexin have received some attention as constituents of plants used in traditional Chinese medicine (TCM). Li et al. [79] determined the pharmacokinetics and tissue distribution of orientin after a single intravenous administration of the pure compound (20 mg /kg body weight) to rats. Orientin was rapidly distributed and eliminated from the plasma within 90 min. It was detected after 5 min in all tissues tested, which included the heart, liver, lung, spleen, kidney, brain, stomach and small intestine. The highest levels, ranging from 45.07-60.74 μg/g (after 5 min), were found in the lung, liver and kidney tissue. The compound took slightly longer to reach the maximum level in the brain, and the concentration was much lower. Low levels of orientin in the brain were attributed to it having difficulty crossing the bloodbarrier because of its high polarity. Oral bioavailability was also tested with a higher dose, but no orientin could be detected in the plasma, indicating poor absorption from the rat gastrointestinal tract.
An ADME study of bamboo extract (gavaged at 1 g/kg body weight), containing orientin, isoorientin, vitexin and isovitexin as major constituents, showed poor gastrointestinal absorption of these compounds in rats [78] . None of the compounds could be detected in the blood, indicating that they could not enter the liver through the portal vein and be involved in the enterohepatic cycle. The compounds were also not detected in the urine. More than 50% of the compounds were excreted in the original form within 12 h.
Metabolism of the flavones by gut microflora entailed deglycosylation followed by scission of the heterocyclic C ring [78] . Phloroglucinol, hydrocaffeic acid (3-(3,4-dihydroxyhydrocinnamic acid; dihydrocaffeic acid) and phloretic acid were identified as metabolites. It was proposed that the glucoside moiety is removed to give the aglycones, luteolin and apigenin, or that the flavanones, eriodictyol-and naringenin-C-glucoside are formed, which in turn are deglycosylated into the flavanone aglycones, eriodictyol and naringenin. The flavanone aglycones are subsequently subjected to scission of the heterocyclic C ring, forming phloroglucinol and phenolic acids, with orientin and isoorientin giving hydrocaffeic acid and vitexin and isovitexin phloretic acid. The proposed metabolic pathway of Zhang et al. [78] , adapted to include breakdown of luteolin to eriodictyol according to Blaut et al. [69] , is depicted in Figure 4 . This is in agreement with the findings of Hattori [59] , showing that incubation of isoorientin with human intestinal bacteria resulted in the formation of 6-C-glucosyleriodictyol, eriodictyol, luteolin, hydrocaffeic acid and phloroglucinol. Hydrocaffeic acid is a metabolite of eriodictyol [80] .
Blaut et al. [69] proposed that luteolin can also be converted to eriodictyol. Incubation of vitexin with bacteria isolated from the caecal lumen of pigs, showed that the hydrolysis of the C-glycosidic bond was 5 times slower than for an O-glycosidic bond [61] . More than 80% of vitexin was still detectable after 1 hour of incubation and complete metabolism occurred between 4 to 6 h of incubation.
Mangiferin, as a C-glucoside, also has poor absorption. Analysis of the plasma of rats [81] and pigs [82] after oral administration of, respectively, pure mangiferin (single dose of 50-500 mg/kg body weight) and an extract of unfermented honeybush (Cyclopia genistoides), equaling 75 mg xanthones/kg body weight/day, failed to detect mangiferin. The xanthones comprised mangiferin and isomangiferin. Norathyriol, the aglycone of mangiferin, was detected in the pig plasma, indicating deglycosylation of mangiferin in the intestine, followed by absorption from the colon into the blood circulation. The C-glucosyl bond of mangiferin is cleaved by human intestinal bacteria [60, 83, 84] . Norathyriol appeared after 12 h incubation and peaked at 36 h [60] . However, a number of other bioavailability studies of mangiferin in rats showed its presence in the plasma [85] [86] [87] . When administering a dose of pure mangiferin (120 mg/kg body weight), a low mangiferin concentration was detected in the plasma, indicating poor absorption from the gastrointestinal tract and possibly the result of the hepatic first pass effect [86] . T max in the plasma was reached after 4.87 h. In the same study mangiferin in the urine peaked at 6 h after administration. Cumulative excretion of mangiferin was only 6.52% of the administered dose.
Mangiferin absorption from three TCM plant extracts reached, respectively, T max of 5 [85] , 5.8 [88] and 4.2 h in the plasma [87] after oral administration of the extracts to rats. Mangiferin was extensively distributed in most of the main tissues of rats [87] .
Intravenous administration of mangiferin to rats showed that its mean retention in blood was 35.0 to 45.8 min, over the dose range 10 to 100 mg/kg body weight [89] . Analysis of the bile showed four major peaks, tentatively identified as mangiferin conjugates containing both a methyl and glucuronide group, a sulphate group and methyl group. For the latter compound two peaks with the same m/z (435) were detected, suggesting different positions for methylation.
Mangiferin and the metabolites, 1,7-dihydroxyxanthone (euxanthone) and its glucuronide, were detected in the urine of rabbits [90] . Metabolites identified in rat urine after ingestion of a single dose of 120 mg mangiferin/kg body weight were 1,3,7trihydroxyxanthone, the major metabolite, 1,3,6,7tetrahydroxyxanthone (norathyriol), 1,3,6-trihydroxy-7-methoxyxanthone and 1,7-dihydroxyxanthone [91] . Maximum excretion of norathyriol was observed from 12 to 24 h, while the other metabolites peaked from 24 to 36 h. The proposed metabolic degradation of mangiferin is depicted in Figure 5 . In addition to the presence of unconjugated mangiferin in rat urine the presence of phase II metabolites was confirmed [92] . comprised a glucuronide and monomethyl conjugate, a monomethyl conjugate and a dimethyl conjugate.
The urine of pigs, fed mangiferin-enriched C. genistoides extract, contained norathyriol, its monoglucuronide and methyl mangiferin [82] . No free mangiferin or sulphated metabolites were detected. Excretion of the metabolites, especially norathyriol, and its monoglucuronide, was not yet completed 72 h after the last intake. Rabbits, fed pure mangiferin, took 96 h to totally excrete mangiferin [90] .
The bioavailability of hesperidin, narirutin and eriocitrin, all 7-O-rutinosyls, has received attention as these compounds are common in citrus fruits. Their sugar moiety is a major determinant of their bioavailability. Flavonoids with the rutinosyl group in the 7 position are not a substrate for human liver and small intestine β-glucosidases [93] . Perfusion of isolated rat jejunum and ileum with hesperidin showed that no absorption of hesperidin took place, and no hesperetin (aglycone) or glucuronidation products could be detected [94] . Removal of rhamnose improves the absorption of the remaining flavonoid glucoside [95] . Absorption of rutinosides is much slower than their corresponding aglycone or glucosides, since absorption after hydrolysis by colonic bacteria occurs from the caecum [96] . The conjugated aglycones are found in plasma, urine and bile [96] [97] [98] .
Eriocitrin could not be detected in the plasma of rats gavaged with an aqueous solution of the compound [99] . Metabolites detected in plasma collected after 4 h were glucuronidated and/or sulphated conjugates of eriodictyol, homoeriodictyol and hesperetin. The latter two compounds showed that methylation in the liver occurred. A small quantity of both the free and conjugated form of hydrocaffeic acid was also present in the plasma after 4 h. Unconjugated and conjugated forms of the flavanones, as well as a small quantity of hydrocaffeic acid were detected in urine collected after 24 h. Total flavonoid absorption was estimated as 5.68%. Similar results were found for human plasma after ingestion of an eriocitrinenriched extract of lemon peel [100] . Human intestinal bacteria metabolise eriocitrin to eriodictyol, hydrocaffeic acid and phloroglucinol [101] ( Figure  6 ). Another proposed degradation pathway for flavanones entails isomerisation of the flavanone to a chalcone followed by its reduction to a dihydrochalcone, which is then hydrolysed to phloroglucinol and hydrocaffeic or phloretic acid, depending on the hydroxylation pattern of the flavanone [102] . A chalcone isomerase, isolated from the human fecal anaerobe Eubacterium ramulus, catalyses the isomerisation of naringenin chalcone to naringenin [103] .
A bioavailability study of hesperidin and narirutin in humans, consuming orange juice, showed that no intact glycosides or aglycones could be detected in the plasma [98] . Hesperidin metabolites recovered from the plasma were glucuronides (83%) and sulphoglucuronides (13%) of hesperetin. Similarly, only conjugates of hesperetin and naringenin were found in the urine. In rats, hesperidin is primarily converted to hesperetin-3´-O-glucuronide and hesperetin-7-O-glucuronide [104] .
Clearly rooibos and honeybush flavonoids will be metabolised and absorbed largely in the colon. Due to structural similarities of the parent compounds, many intermediate and degradation products behave the same. Antioxidant effects are retained in many cases, although potency and efficacy may be affected. The degradation product, hydrocaffeic acid, was shown to scavenge intracellular ROS [105] .
Herb-drug interactions
Herb-drug interactions occur at many different levels in the body and may affect the absorption, distribution, metabolism and excretion of certain drugs [106] . Although certain herb-drug interactions exhibit beneficial effects in enhancing the effects of various pharmaceuticals utilised in cancer chemotherapy and in the treatment of liver disease, potentially negative interactions, e.g. interfering with platelet function, corticoid treatment of inflammatory conditions and anti-depressant drugs are also possible [107] .
Numerous studies have been conducted on herb-drug interactions of flavonoids (flavanones including the aglycones hesperetin, naringenin and eriodictyol, as well as their corresponding glycosides hesperidin, naringen and eriocitrin). Most of these interactions, studied in the small intestine, concerned the modulation of drug transport and metabolism, which involves ABC transport proteins including P-glycoprotein (P-gp), organic cation transporter (OCT) and the cytochrome P450 (CYP450) isoforms [66, 108, 109] . Studies in Caco-2 cells showed that hesperetin, naringenin, rutin, isoquercitrin and quercetin inhibited OCT-mediated transport and also interfere with the secretary transport process, presumably via interaction with P-gp [66, 109] . This would imply that flavonoids may affect the bioavailablity of a variety of drugs, food ingredients and/or toxic compounds as well as multidrug resistance in cancer cells. Another important modulating role of the flavonoids is the inhibitory effect of the drug metabolising enzyme, CYP450. Inhibition of CYP3A4, the predominant CYP in the intestine, increased the oral availability of certain drugs thereby increasing their peak serum concentrations leading to toxicity. The induction of these enzymes on the other hand may cause reduced drug concentrations and a reduction in efficacy. The inhibition of CYP3A4 by quercetin and the flavanones, narirutin and hesperidin has been reported [110, 111] . A recent study showed that rooibos increased the expression of CYP3A4 in the intestine which coincided with a decreased level of the drug Midazolam in the serum after oral administration [112] . The hepatic content and metabolism of the drug was also slightly increased. Both South African herbal teas contain flavonoids that potentially may effect certain herb-drug interactions. In this regard, honeybush contains high levels of the flavavone, hesperidin and lower levels of hesperetin and naringenin. Rooibos contains low levels of quercetin and luteolin known to modulate the activity of CYP3A4. No studies have been conducted on the herb-drug interactions concerning mangiferin and aspalathin.
Conclusions
Tea flavonoids make a major contribution to the average dietary intake of polyphenols in humans. Herbal teas have become more popular recently due to the potential health properties and the presence of unique polyphenolic constituents. Although emphasis is placed on their antioxidant potential, their anticancer properties have recently been investigated in vitro and in different animal cancer models. However, complex polyphenol-diet-xenobiotic interactions seem to exist which will provide information regarding their role in prevention of human disease. Rooibos contributes a unique flavonoid, the dihydrochalcone, aspalathin, and some uncommon flavonoids to the diet, while honeybush is a good source of the xanthone, mangiferin. Irrespective of the parent flavonoids, many intermediate metabolites and degradation products are similar, especially when considering microbial metabolism in the gut. Ample evidence of the beneficial effects of the individual polyphenolic constituents of the herbal teas exists. To determine their respective role(s) in the context of the possible health properties of rooibos and honeybush herbal teas, future research should address their bioavailability and herb-drug interactions.
